Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Two-Session Meaning-Making program ease fatigue after cancer?

NCT ID NCT07836075

Symptom relief Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers at the University of Hong Kong are testing a brief group wellness program for young adult cancer survivors aged 18 to 39 who have finished primary treatment. The program uses two in-person sessions based on Viktor Frankl's existential psychology, with discussions, stories, and reflective activities. The study aims to see if this approach is feasible and whether it might improve fatigue and other symptoms compared with usual care. Participants complete questionnaires at the start, one week after the program, and one month later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a brief group meaning-making wellness program based on Viktor Frankl's existential psychology
What this could lead to
If it works, this could offer a low-cost, non-drug way to help young adult cancer survivors manage fatigue and related symptoms after treatment.
What could go wrong
This is a small feasibility study of 50 people, so it may not show clear benefits or may not apply to other survivor groups. The program requires attending two in-person group sessions, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 39 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cancer survivors currently aged 18-39, including who are currently either cancer-free, in remission, or receiving maintenance therapy. * Having completed primary cancer treatment for at least about 2 months. * Able to speak, read, and comprehend Cantonese, and able to comprehend English. * Ambulatory * No auditory, visual or language or reading disabilities (e.g. aphasia, deafness) * Able to complete online questionnaires. * Able to use laptop. * Willing to accept randomization. Exclusion Criteria: * Current severe or untreated psychiatric disorder that would preclude participation in class activities. * Displaying any psychotic symptoms which would hinder class participation. * Having physical, sensory disabilities or cognitive impairment that would preclude face-to-face class. attendance and group-based interaction. * Unwilling to accept randomization. * Currently receiving any type of psychotherapy * Having received any Franklian existential psychology-related interventions, Logotherapy or Meaning-centred Psychotherapy before. Remark: Some inclusion and exclusion criteria are purposely omitted at this time to preserve scientific integrity. They will be included after the trial is complete.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent and young adult cancer survivors are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent and young adult cancer survivors Cancer survivorship Wellness program

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The University of Hong Kong

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.